A Study of F182112 in the Treatment of Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT07312188 · RECRUITING
Trial details
- NCT number
- NCT07312188
- Sponsor
- Shandong New Time Pharmaceutical Co., LTD
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-02
- Primary completion
- 2028-05-20
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.